1 results match your criteria: "Northern Michigan Regional Hospital Heart and Vascular Institute[Affiliation]"
The XIENCE nano everolimus eluting coronary stent system for the treatment of small coronary arteries: the SPIRIT Small Vessel trial.
Catheter Cardiovasc Interv
October 2012
Northern Michigan Regional Hospital Heart and Vascular Institute, Petoskey, Michigan, USA.
Objectives: The SPIRIT Small Vessel (SV) was designed to evaluate the safety and effectiveness of the 2.25-mm XIENCE V everolimus eluting coronary stent system (EECSS), known as the XIENCE nano EECSS, in subjects with SVs and ischemic heart disease.
Background: The core sizes of XIENCE V EECSS are associated with low rates of restenosis and thrombosis in the general population, but the XIENCE nano EECSS has not been tested in the United States.